Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12738
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWight, Jen
dc.contributor.authorMorris, Een
dc.contributor.authorStillwell, Aen
dc.contributor.authorGrant, Ben
dc.contributor.authorLai, H Cen
dc.contributor.authorIrving, Ien
dc.date.accessioned2015-05-16T02:28:15Z
dc.date.available2015-05-16T02:28:15Z
dc.date.issued2015-04-14en
dc.identifier.citationInternal Medicine Journal; 45(7): 762-5en
dc.identifier.govdoc25870934en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12738en
dc.description.abstractMagnetic Resonance Imaging (MRI) is the most sensitive method for detecting focal spinal disease (FSD) in multiple myeloma (MM). It is unclear whether whole spine MRI (WS-MRI) should be employed as a screening test at diagnosis of MM.To determine the utility of screening WS-MRI at diagnosis of MM.A retrospective analysis of data from January 2008 to January 2013 at The Townsville Hospital was performed. At this centre, WS-MRI is used routinely in all newly diagnosed MM. The findings of WS-MRI in patients with and without an agreed guideline indication for WS-MRI were compared. Clinical predictors of FSD were determined.71 patients were included in the analysis. 44 (62%) had an agreed indication for MRI; 33 (75%) of these had FSD. Within this group, 17 required urgent intervention and 13 had spinal plasmacytomas. Within a second group without a guideline indication, 4 of 27 (15%) were found to have FSD on MRI - none required urgent intervention and or had plasmacytomas. 3 of 8 smouldering myeloma patients were reclassified as symptomatic myeloma by documenting lytic lesions not identified on plain film. The strongest predictors of FSD were back pain (p<0.001) and vertebral compression fracture (p=0.003).WS-MRI in patients without a guideline indication did not detect any lesions that threatened the spinal cord. WS-MRI is essential in those with guideline indications. WS-MRI is of benefit to patients with smouldering myeloma where documentation of lesions not seen on plain film will result in treatment rather than observation.en
dc.language.isoenen
dc.subject.otherMRI spineen
dc.subject.otherMultiple Myelomaen
dc.subject.otherPlasmacytomaen
dc.subject.otherSmouldering Myelomaen
dc.titleScreening whole spine Magnetic Resonance Imaging (MRI) in multiple myeloma.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternal Medicine Journalen
dc.identifier.affiliationAustin health service, department of haematology; James Cook University, School of Medicine and Dentistry.en
dc.identifier.doi10.1111/imj.12789en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25870934en
dc.type.austinJournal Articleen
item.languageiso639-1en-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Feb 1, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.